Legal & General Group
NVAX icon

Legal & General Group’s Novavax NVAX Stock Holding History

Legal & General Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Sell
125,900
-26,325
-17% -$239K ﹤0.01% 2137
2025
Q4 		$1.02M Sell
152,225
-3,518
-2% -$26.5K ﹤0.01% 2208
2025
Q3 		$1.35M Buy
155,743
+1,529
+1% +$11.9K ﹤0.01% 2149
2025
Q2 		$972K Buy
154,214
+97
+0.1% +$642 ﹤0.01% 2251
2025
Q1 		$987K Buy
154,117
+6,059
+4% +$50.1K ﹤0.01% 2191
2024
Q4 		$1.19M Buy
148,058
+13,056
+10% +$126K ﹤0.01% 2175
2024
Q3 		$1.71M Buy
135,002
+380
+0.3% +$4.91K ﹤0.01% 2042
2024
Q2 		$1.7M Buy
134,622
+21,991
+20% +$221K ﹤0.01% 2009
2024
Q1 		$538K Buy
112,631
+13,286
+13% +$61.6K ﹤0.01% 2395
2023
Q4 		$477K Buy
99,345
+2,657
+3% +$16.3K ﹤0.01% 2472
2023
Q3 		$700K Sell
96,688
-9,177
-9% -$73.3K ﹤0.01% 2310
2023
Q2 		$787K Buy
105,865
+39,414
+59% +$310K ﹤0.01% 2301
2023
Q1 		$461K Sell
66,451
-4,926
-7% -$45.3K ﹤0.01% 2331
2022
Q4 		$734K Sell
71,377
-3,082
-4% -$54.4K ﹤0.01% 2235
2022
Q3 		$1.36M Sell
74,459
-7,212
-9% -$313K ﹤0.01% 2045
2022
Q2 		$4.2M Sell
81,671
-158,083
-66% -$8.19M ﹤0.01% 1497
2022
Q1 		$17.7M Buy
239,754
+21,947
+10% +$1.96M 0.01% 915
2021
Q4 		$31.2M Sell
217,807
-13,956
-6% -$2.4M 0.01% 799
2021
Q3 		$48M Buy
231,763
+2,704
+1% +$596K 0.02% 680
2021
Q2 		$48.6M Buy
229,059
+184,500
+414% +$33.8M 0.02% 695
2021
Q1 		$8.08M Buy
44,559
+3,988
+10% +$795K ﹤0.01% 1333
2020
Q4 		$4.53M Buy
40,571
+5,358
+15% +$569K ﹤0.01% 1504
2020
Q3 		$3.81M Buy
35,213
+20,767
+144% +$2.53M ﹤0.01% 1477
2020
Q2 		$1.2M Buy
14,446
+8,943
+163% +$342K ﹤0.01% 1922
2020
Q1 		$75K Sell
5,503
-230
-4% -$1.95K ﹤0.01% 2490
2019
Q4 		$23K Sell
5,733
-413
-7% -$1.79K ﹤0.01% 3144
2019
Q3 		$31K Buy
6,146
+1,004
+20% +$5.5K ﹤0.01% 2950
2019
Q2 		$32K Buy
5,142
+1,423
+38% +$11.2K ﹤0.01% 2982
2019
Q1 		$41K Hold
3,719
– – ﹤0.01% 2780
2018
Q4 		$137K Buy
3,719
+878
+31% +$34K ﹤0.01% 2390
2018
Q3 		$107K Hold
2,841
– – ﹤0.01% 2497
2018
Q2 		$76K Buy
2,841
+79
+3% +$2.67K ﹤0.01% 2579
2018
Q1 		$116K Sell
2,762
-1,003
-27% -$40.3K ﹤0.01% 2447
2017
Q4 		$95K Sell
3,765
-642
-15% -$15.7K ﹤0.01% 2605
2017
Q3 		$101K Buy
4,407
+594
+16% +$13.3K ﹤0.01% 2645
2017
Q2 		$88K Hold
3,813
– – ﹤0.01% 2668
2017
Q1 		$98K Sell
3,813
-1,105
-22% -$30.4K ﹤0.01% 2553
2016
Q4 		$124K Buy
4,918
+1,827
+59% +$53.3K ﹤0.01% 2428
2016
Q3 		$125K Sell
3,091
-431
-12% -$55.6K ﹤0.01% 2151
2016
Q2 		$510K Buy
3,522
+485
+16% +$55.6K ﹤0.01% 1338
2016
Q1 		$318K Buy
3,037
+412
+16% +$44.2K ﹤0.01% 1553
2015
Q4 		$439K Buy
2,625
+138
+6% +$21.2K ﹤0.01% 1368
2015
Q3 		$369K Buy
2,487
+72
+3% +$16.1K ﹤0.01% 1388
2015
Q2 		$528K Buy
2,415
+427
+21% +$75.1K ﹤0.01% 1310
2015
Q1 		$338K Buy
1,988
+412
+26% +$66.9K ﹤0.01% 1422
2014
Q4 		$186K Hold
1,576
– – ﹤0.01% 1611
2014
Q3 		$133K Buy
+1,576
New +$142K ﹤0.01% 1715

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legal & General Group's NVAX Position: Q1 2026 in Review

Legal & General Group reduced its Novavax (NVAX) stake by 17% in Q1 2026, selling an estimated $239K and leaving 125,900 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

Legal & General Group first reported a position in NVAX in Q3 2014 and has held it in 47 quarters since. The position peaked at $48.6M in Q2 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Legal & General Group held 125,900 shares of Novavax worth $1.02M as of Q1 2026.
  • Legal & General Group sold 26,325 Novavax shares in Q1 2026, an estimated $239K.
  • Novavax made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2137 holding.
  • Legal & General Group first reported a position in Novavax in Q3 2014 and has held it in 47 quarters since.
  • Legal & General Group's Novavax position peaked at $48.6M in Q2 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.